Inventiva SA ADR IVA 深 沪
已收盘 07-02 16:00:00 美东时间
3.91
+0.220
+5.96%
华盛通- 最 高3.965
- 今 开3.70
- 成交量 183.26万股
- 最 低 3.67
- 昨 收 3.69
- 总市值 9.24亿
- 52周最高 7.9825
- 市盈率 静 --
- 换手率 0.78%
- 52周最低 2.8536
- 委 比 62.45%
- 总股本 2.36亿
- 历史最高 19.064
- 量 比 1.08
- 振 幅 7.99%
- 历史最低 1.53
- 每 手 1
- 风险率 1.05%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Arrowstreet Capital reports net short position in Inventiva shares
Arrowstreet Capital reports net short position in Inventiva shares Arrowstreet Capital disclosed a 0.6% net short position in Inventiva shares, up from 0.6% previously. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives
06-15 22:14
Super Micro Computer, Summit Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures were lower this morning, with the Nasdaq futures falling around 1% on Wednesday. Shares of Super Micro Computer Inc (NASDAQ:SMCI) fell sharply in pre-market trading after the company announced a proposed offering to fund AI orders. Super Micro announced a series of offerings expec...
06-10 20:03
Arrowstreet Capital discloses net short position in Inventiva
Arrowstreet Capital discloses net short position in Inventiva Arrowstreet Capital disclosed a 0.5% net short position in Inventiva shares as of 2026-06-03. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide ac
06-04 22:51
Inventiva Halts Paris Trading Ahead of Planned Financing Announcement, Shares Expected to Resume Trading Later Tuesday
Inventiva (NASDAQ:IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated steatohepatitis
06-02 16:36
Inventiva reports JPMorgan beneficial stake at 5.25% of capital, 5.03% voting rights
Inventiva reports JPMorgan beneficial stake at 5.25% of capital, 5.03% voting rights JPMorgan Chase cut its stake in Inventiva below the 5% voting-rights threshold on May 11, holding 10,805,364 shares, equal to 5.2% of capital and 4.98% of voting rights. The holding moved back above 5% of voting rig
05-18 22:38
Inventiva Bolsters C-Suite Ahead of Lanifibranor Phase 3 Readout
Inventiva ( ($IVA) ) has issued an update. Inventiva announced on April 22, 202...
04-23 05:00
Inventiva announces CFO appointment
Inventiva (IVA) appointed Axel-Sven Malkomes as chief financial officer. Former CFO Jean Volatier becomes EVP Finance & CSR. Malkomes brings 30+ years of experience, including prior roles at CureVac a...
04-23 04:21
Inventiva Recruits Axel-Sven Malkomes As New CFO
Inventiva also added Susan Coles as Chief Legal Officer, and Pamela Herbster as Chief People Officer.
04-23 04:02
Inventiva says JPMorgan holds 6% stake, 5.6% voting rights
Inventiva says JPMorgan holds 6% stake, 5.6% voting rights JPMorgan Chase crossed above 5% of voting rights in Inventiva on April 1. Holding totaled 12,551,345 shares, equal to 6% of share capital. Voting rights stake stood at 5.6%. Disclosure cited an increase in shares held through positions treat
04-09 22:56
Inventiva SA Bets Big on Pivotal MASH Trial
Inventiva SA (($FR:IVA)) has held its Q4 earnings call. Read on for the main hi...
04-05 08:26
